Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

Appili Therapeutics had revenue of 103.94K CAD in the quarter ending September 30, 2025, with 2,116.10% growth. This brings the company's revenue in the last twelve months to 199.69K, down -59.64% year-over-year. In the fiscal year ending March 31, 2025, Appili Therapeutics had annual revenue of 100.44K, down -87.86%.

• Revenue (ttm): 199.69K
• Revenue Growth: -59.64%
• P/S Ratio: 12.86
• Revenue / Employee: 28.53K
• Employees: 7
• Market Cap: 2.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	100.44K	-726.96K	-87.86%
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-